I’m still new to this group but it looks like we have a pretty good age distribution, a high level of health awareness, and for many among us, rapamycin is but one among many supplements we take to improve our health and longevity.
Now in my 70s, I have been taking nutritional supplements since I was 24, adding and dropping supplements or changing doses along the way as the profile of evidence changed over the years. Those of you who were taking supplements around the time I started know how little good research there was to inform risk/benefit decisions.
Nonetheless, it was possible to find research that supported mostly rational decisions about whether to take a specific supplement. One of my informal decision rules at that time was to weigh downside risk much more heavily on upside benefit. I was not averse to taking a supplement for which the benefit was probable but as yet unproven, but I avoided supplements where the evidence of risk was stronger, irrespective of the benefits. (Of course, price and my budget figured in someplace.)
Now, some 50 years later, even though the number of supplements I take has expanded from a half dozen to five times that, my basic decision criteria have not changed substantially, with one exception. That exception is rapamycin. As a longevity drug, the list of probable benefits to someone my age is growing and they are significant. However, I’m not certain evidence for any of those probable benefits has crossed the line of generalized certainty based on large-n, multi-trait/multi-method (including randomized case control) evidence such as we have for many supplements. The risks of taking rapamycin, some of them at least, are clearer, albeit often derived from a different use of the drug. One somewhat theoretical risk I personally wonder about is if rapamycin might unfavorably tip a delicate balance of power between my immune system’s successful battle with a few nascent cancer cells of which I am unaware.
How do others formulate their risk/benefit decisions? Have you altered your general approach to making these decisions when it comes to taking rapamycin? I have changed my standards, I think, because the probable benefits seem more important to me at my age. If I were 25 years younger, I think I would be on the sidelines until we had at least a little more human evidence. Are others in our group still waiting and watching?